The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Krempa David since 2026.
This trader's CIK number is 1968254.
At the time of last reporting, Krempa David was the Chief Business Officer of Eton Pharmaceuticals, Inc.. (stock ticker symbol ETON).
Also see all insider trading activities at Eton Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ETON | 0 | $0 | 100,000 | $3,257,672 | 87,794 | $209,815 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-22 | ETON | Option Ex | 30,591 | 3.58 | 109,515 |
| 2026-05-27 | ETON | Sale | 19,679 | 31.47 | 619,376 |
| 2026-05-26 | ETON | Sale | 37,524 | 31.49 | 1,181,743 |
| 2026-05-27 | ETON | Option Ex | 19,679 | 2.48 | 48,705 |
| 2026-05-26 | ETON | Option Ex | 37,524 | 1.38 | 51,595 |
| 2026-05-22 | ETON | Sale | 42,797 | 34.03 | 1,456,553 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krempa David (Chief Business Officer of Eton Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.